Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 6 : Hundreds of safety violations in Wake Schools uncovered in WRAL investigation raise questions of student safety.
Program
On FOX 50 at 10: The State Fair and a sold-out concert cause traffic chaos. How the Lenovo Center is responding to the backlash
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALF
Recent news which mentions ESALF
< Previous
1
2
Next >
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
ESALY
Health Care
Benzinga
From
Benzinga
Medicare unveils plan for coverage of new Alzheimer’s drugs
June 01, 2023
Tickers
BIIB
ESALF
LLY
Tags
LLY
ESALF
BIIB
From
MarketWatch
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
May 04, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Health Care
LLY
ESALF
From
Benzinga
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
April 21, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Briefs
Government
Biotech
From
Benzinga
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
April 10, 2023
Tickers
ESALF
ESALY
MRK
Tags
Benzinga
ESALF
ESALY
From
Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
April 03, 2023
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Market News
News
From
Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
March 31, 2023
Tickers
BIIB
ESALF
ESALY
Tags
ESALY
Health Care
ESALF
From
Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
March 16, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Health Care
Regulations
LLY
From
Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
March 14, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
BIIB
ESALF
From
Benzinga
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
March 06, 2023
Tickers
BIIB
ESALF
ESALY
Tags
FDA
BIIB
General
From
Benzinga
The 7 Best Growth Stocks to Buy for February 2023
February 06, 2023
Tickers
ACLS
CPRX
DAR
ESALF
Tags
PFGC
ESALF
ICLR
From
InvestorPlace
New Alzheimer’s drug shows some promise, but has big price tag
February 02, 2023
Tickers
BIIB
ESALF
Tags
ESALF
JP:4523
BIIB
From
MarketWatch
FDA Approves Biogen's Second Alzheimer's Treatment Under Accelerated Pathway
January 06, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Large Cap
News
Health Care
From
Benzinga
Biogen's Alzheimer's Antibody Might Have A Third Death Associated With
December 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Market News
BIIB
General
From
Benzinga
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
December 20, 2022
Tickers
CPRX
ESALF
ESALY
Tags
Biotech
Movers
Benzinga
From
Benzinga
Despite Safety Concerns, Analysts Are Bullish On Biogen's Second Alzheimer's Candidate
November 30, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Analyst Color
BIIB
From
Benzinga
Open Questions On Safety Lingers After Eisai-Biogen's Detailed Lecanemab Data For Alzheimer's
November 30, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Biotech
Benzinga
ESALF
From
Benzinga
Biogen's Potential Early Alzheimer's Treatment Sees Second Death Linked To It, Shares Fall
November 28, 2022
Tickers
BIIB
ESALF
ESALY
Tags
General
Briefs
Biotech
From
Benzinga
One Alzheimer’s drug has failed, but investors are still betting on Biogen and Lilly treatments
November 14, 2022
Tickers
BIIB
ESALF
LLY
MOR
Tags
BIIB
PRTA
JP:4523
From
MarketWatch
Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers
November 14, 2022
Tickers
BIIB
ESALF
ESALY
MOR
Tags
RHHBF
General
Small Cap
From
Benzinga
Despite Advancement, Benefits From Alzheimer's Drugs May Be Limited, Say Researchers
October 10, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
General
Biotech
Benzinga
From
Benzinga
Medicare coverage of Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
September 28, 2022
Tickers
BIIB
ESALF
SPX
Tags
SPX
ESALF
JP:4523
From
MarketWatch
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
September 12, 2022
Tickers
ESALF
ESALY
MRK
Tags
Market News
General
MRK
From
Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
Tickers
ESALF
ESALY
LLY
RHHBF
Tags
ESALY
Benzinga
Biotech
From
Benzinga
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
August 03, 2022
Tickers
ESALF
ESALY
MRK
Tags
News
Briefs
Large Cap
From
Benzinga
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
July 06, 2022
Tickers
AMTI
BIIB
ESALF
ESALY
Tags
Benzinga
Biotech
PHGE
From
Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Tickers
AGEN
ARWR
ATNX
AVGR
Tags
CALA
ESALF
Trading Ideas
From
Benzinga
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
News
Briefs
Biotech
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Market News
News
From
Benzinga
FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer
March 22, 2022
Tickers
ESALF
ESALY
MRK
Tags
Market News
MRK
FDA
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.